Nuvigil and Provigil Pregnancy Registry
Study Title
- The Nuvigil and Provigil Pregnancy Registry
Teva Identifier
- C10953/9022
ClinicalTrials.gov Identifier
- NCT01792583
Study Status
- Recruiting
Trial Condition(s)
- Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder
Interventions
- Drug: Modafinil/armodafinil
Study Description
- The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during
Key Participation Requirements
Gender
- Female
Age Range
- Child, Adult, Older Adult
Trial Duration
- June 30, 2009 - January 31, 2027
Study Type
Observational
Location - Where to Participate
You may contact 1-888-483-8279 or email USMedInfo@tevapharm.com to obtain more information about study locations.
